Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
uber Head and Shoulder
Thanks.
They have 25% discount also.
https://tmwpay.com/Fashion/offers
30 days trading under $1. NASDAQ non-compliant letter coming soon!
Short Squeeze!
STAY LONG!
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=RBZ.O
The bulls are strong!
It is about that time.
RBZ Regained NASDAQ Compliance.
https://listingcenter.nasdaq.com/noncompliantcompanylist.aspx
They sell on Ebay also
https://feedback.ebay.com/ws/eBayISAPI.dll?ViewFeedback2&userid=reebonzus&myworld=true&items=25&iid=-1&de=off&which=positive&interval=365
Look at the feedback
In England they don't have Sell Back Guarantee
https://www.reebonz.com/gb/designer-bags
They are also selling in Europe.
Denmark
https://www.reebonz.com/dk/designer-bags
France
https://www.reebonz.com/fr/designer-bags
Germany
https://www.reebonz.com/de/designer-bags
Ireland
https://www.reebonz.com/IE/designer-bags
Sweden
https://www.reebonz.com/se/designer-bags
Spane
https://www.reebonz.com/es/designer-bags
Norway
https://www.reebonz.com/no/designer-bags
Italy
https://www.reebonz.com/it/designer-bags
Switzerland
https://www.reebonz.com/ch/designer-bags
RBZ: Roth Capital initiated to "Buy"
Yes RBZ will be in this list after 11:00 PM EST.
This is an old news. Real news is about to come. May be at the close today or Monday.
Here we go!!!
One of the Intel CEO Candidates:
Apple will not just buy Kodak patents but also buy the whole camera division along with employees. Like what google did with Motorola. That is what taking longer time. Kodak is slowly selling parts where Apple is not interested such as Kodak Gallery and Sensor division.
Why would they inject more if they see improvement with less (50,000 cell) and it is safe.
11/787,262 HEMANGIO-COLONY FORMING CELLS
Methods of generating and expanding human hemangio-colony forming cells and non-engrafting hemangio cells in vitro and methods of expanding and using such cells are disclosed. The methods permit the production of large numbers of hemangio-colony forming cells, non-engrafting hemangio cells as well as derivative cells, such as hematopoietic and endothelial cells. The cells obtained by the methods disclosed may be used for a variety of research, clinical, and therapeutic applications. Human non-engrafting hemangio cells are a novel progenitor cell population that is related to but distinct from the hemangioblast and human hemangio-colony forming cells. The invention also provides compositions, preparations, and solutions comprising hemangio-colony forming cells, non-engrafting hemangio cells or cells differentiated therefrom. The compositions, preparations, and solutions include cryopreserved preparations and substantially purified preparations, as well as mixed compositions formulated in combination with related hemangioblast progenitor cell types that can engraft into the bone marrow.
New Patent on September 19th.
Another Conference on September 14th in Boston:
http://www.terrapinn.com/2011/stem-cells-usa-and-regenerative-medicine-congress/
ACTC presenting in Rodman & Renshaw on September 11-13
http://www.rodmanandrenshaw.com/conferences?id=162&link=presenters
Issue notification Mailed:
11/787,262 HEMANGIO-COLONY FORMING CELLS
New Patent:
11/787,262 HEMANGIO-COLONY FORMING CELLS
Results from Korea?
RPE attachment to Bruch's membrane. We may know the answer by next week.
Shorts do not want you to know this:
http://www.businesswire.com/news/home/20110719006201/en/Research-Markets-Superconductivity-7th-Era-Coming-Revolution
In some instances, the dry stage of macular degeneration can turn into the wet stage. If ACTC treats or prevent Dry AMD there will be less cases of wet AMD. This is how I understand.
Gary will exercise ACTC options after SHM.IMHO
Today volume was lowest in recent weeks. Any comments?
http://www.rpbusa.org/rpb/
CEOCAST this weekend:
Advanced Cell Technology (OTCBB: ACTC), a leader in regenerative medicine, announced that the Oregon Health and Science University Institutional Review Board (IRB) has given approval for their center to be a clinical trial site for ACTC’s Phase I/II clinical trial using retinal pigment epithelial cells (RPE) derived from human embryonic stem cells (hESCs) in the treatment of macular degeneration. The Casey Eye Institute (CEI) at Oregon Health and Science University has internal approval to be a part of the prospective, open-label study to determine the safety and tolerability of (RPE) cells following sub-retinal transplantation into patients with Stargardt’s Macular Degeneration (SMD). CEI has successfully collaborated with ACTC’s RPE program since 2007 and will continue this cooperation as a site for this groundbreaking trial of an exciting potential new treatment for SMD. The Casey Eye Institute (CEI) is one of only seven regional eye research centers in the nation sponsored by Research to Prevent Blindness, which is the world’s leading voluntary organization in support of Eye Research. ACTC has also received IRB approval for their Phase I/II trial from the Jules Stein Institute at the University of California, Los Angeles. ACTC stock slipped $0.01 to close last week at $0.20
One thing is correct Caldwell family still own about 7% of ACTC and have not sold any shares.
It all depend who starts the trial(injection) first, if Casey then it will be Stargardt only that will be positive. On the other hand UCLA the AMD and Stargadt.